Harmful and Beneficial Activities of Immunological Adjuvants
There are no officially recognized regulations for the design and toxicity testing of adjuvants or adjuvant formulations; the former are also referred to as immunomodulators and immunopotentiators. At the “Immunological Adjuvants and Vaccines” meeting held in Greece in 1988, however, immunoadjuvant researchers discussed experimental toxicological tests that might be used to monitor new immunomodulators (1 ). The usefulness of these tests for the range of immunomodulators and adjuvant formulations was examined over a 2-yr period and subsequently, at the next NATO meeting in 1990, further recommendations were made (2 ). Although as yet, no final agreement has been reached and a variety of tests are still in use.
- 比较基因组杂交(CGH)
- ABC法检测Thy-1肾炎过程中肾小球内TFPI-1的表达
- 十二烷基硫酸钠―聚丙烯酰胺凝胶电泳(SDS―PAGE)
- 细胞爬片的免疫组化染色的操作步骤
- ELIspot相关试剂、操作工程和技术要点
- 抗体纯化:deae-sephadex a-50 柱层析法
- 肿瘤抗原(肽)和人工合成肽抗原作为肿瘤疫苗
- Transient and Stable Expression of Antibodies in Nicotiana Species
- The IMGT/HLA Database
- Differentiation of Human Antigen-Presenting Dendritic Cells from CD34+Hematopoietic Stem Cells In Vitro